Login / Signup

Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan.

Chen-Hua LiuChun-Jen LiuChien-Ching HungSzu-Min HsiehTung-Hung SuHsin-Yun SunTai-Chung TsengPei-Jer ChenDing-Shinn ChenJia-Horng Kao
Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)
GLE/PIB for 8-16 weeks is effective and well-tolerated for patients with chronic HCV infection in Taiwan.
Keyphrases
  • hepatitis c virus infection
  • hepatitis c virus
  • pet imaging
  • human immunodeficiency virus
  • gestational age
  • preterm birth